Profound Medical Corp. (PROF)

NasdaqCM • Currently down 0.39 (-5.56%) in today's trading session

1 member of Congress has disclosed 10 trades in Profound Medical Corp. (PROF) via STOCK Act filings. The most recent disclosure was a purchase by Tom Malinowski on 21 July 2020. Aggregate disclosed activity totals roughly $80K in purchases (midpoint estimates from bracketed disclosure amounts).

Profound Medical Corp. is currently trading at $6.62, positioned at 44% of its 52-week range ($4.80 – $8.95).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$6.62
24h Change
-0.39 (-5.56%)
52 Week Range
$4.80–$8.95
View on NASDAQ

Profound Medical Corp. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for PROF

Select to highlight on chart
5 transactions
Compliance: 40%
Tom Malinowski21 Jul 20205 Mar 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski21 Jul 202030 Jul 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski21 Jul 202026 Aug 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski27 Jan 202026 Aug 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski27 Jan 202026 Aug 2021PurchaseStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$241.85M

Volume

260.91K

Beta

0.53

P/E Ratio

-6.76

Fundamentals

EPS

$-0.98

Div. Yield

-

Open

$7.01

Day Range

$6.53 – $7.07

Company Information

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ · USD
Country
CA
CEO
Arun Swarup Menawat
IPO Date
2019-10-29
Website
www.profoundmedical.com

Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as...

Earnings

Next Report

Q3 2026

5 Nov

EPS Est.

$-0.19

Rev. Est.

$8.8M

Days Until

21

Recent Quarters

Q2 20266 Aug
EPS$-0.26
Miss 18.2%
Q1 20267 May
EPS$-0.19
Beat 20.8%
Q4 20255 Mar
EPS$-0.27
Beat 0.0%
Q3 202513 Nov
EPS$-0.26
Beat 31.6%
Q2 202514 Aug
EPS$-0.52
Miss 20.9%
Q1 20258 May
EPS$-0.36
Miss 24.1%
Q4 20246 Mar
EPS$-0.20
Beat 35.5%
Q3 20247 Nov
EPS$-0.38
Miss 26.7%
Q2 20248 Aug
EPS$-0.28
Beat 3.5%
Q1 20249 May
EPS$-0.26
Beat 13.3%
Q4 20237 Mar
EPS$-0.42
Miss 31.3%
Q3 20232 Nov
EPS$-0.26
Beat 21.2%
Q2 20239 Aug
EPS$-0.35
Miss 2.9%
Q1 202310 May
EPS$-0.32
Beat 5.9%
Q4 20227 Mar
EPS$-0.46
Miss 27.8%
Q3 20223 Nov
EPS$-0.24
Beat 36.8%
Q2 20224 Aug
EPS$-0.28
Beat 30.0%
Q1 20229 May
EPS$-0.40
Beat 7.0%
Q4 20213 Mar
EPS$-0.49
Miss 32.4%
Q3 20214 Nov
EPS$-0.29
Miss 3.6%
Q2 20214 Aug
EPS$-0.35
Miss 25.0%
Q1 202112 May
EPS$-0.37
Miss 37.0%
Q4 20202 Mar
EPS$-0.38
Miss 40.7%
Q3 20205 Nov
EPS$-0.32
Miss 39.1%
Q2 20206 Aug
EPS$-0.33
Miss 43.5%
Q1 20207 May
EPS$-0.19
Beat 13.6%
Q4 20193 Mar
EPS$-0.33
Beat 8.3%
Q3 20197 Nov
EPS$-0.43
Miss 13.2%
Q2 201914 Aug
EPS$-0.38
Miss 15.2%
Q1 20196 May
EPS$-0.22
Beat 33.3%
Q4 20187 Mar
EPS$-0.50
Miss 11.1%
Q3 20188 Nov
EPS$-0.50
Miss 13.6%
Q2 201814 Aug
EPS$-0.50
Miss 31.6%
Q1 201810 May
EPS$-0.60
Miss 50.0%
Q4 201726 Mar
EPS$-0.60
Miss 20.0%
Q3 20177 Nov
EPS$-0.90
Miss 34.3%
Q2 201723 Aug
EPS$-0.08
Miss 14.3%
Q1 20179 May
EPS$-0.07
Beat 0.0%
Q4 20166 Mar
EPS$-0.07
Beat 0.0%
Q3 201616 Nov
EPS$-0.10
Miss 25.0%
Q2 201618 Aug
EPS$-0.09
Beat 0.0%
Q1 20166 May
EPS$-0.10
Miss 42.9%
Q4 20152 Mar
EPS$-0.42
Q2 201530 Sept
EPS$-0.56
Q1 201530 Jun
EPS$-5.42
Q4 201431 Mar
EPS$-0.56
Q3 201431 Dec
EPS$-2.05
Q2 201430 Sept
EPS$-4.13
Q4 201331 Mar
EPS$-1.55

3 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

16 Oct 2019Reverse Split
Ratio1:10

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

CELC

Celcuity Inc.

47
$59.90-3.29 (-5.21%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

PCRX

Pacira BioSciences, Inc.

47
$36.40+0.09 (+0.25%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

TSLA

Tesla, Inc.

20
$367.16-8.07 (-2.15%)
Consumer Cyclical
Held by same politician
Significant holdings value
1 politician
View Stock

Frequently Asked Questions about PROF

Which members of Congress have traded PROF?
1 member of Congress has disclosed 10 trade in Profound Medical Corp. (PROF) under the STOCK Act: Tom Malinowski.
When was PROF most recently disclosed by Congress?
The most recent PROF disclosure was a purchase by Tom Malinowski on 21 July 2020.
What is the total disclosed congressional trading volume for PROF?
Members of Congress have disclosed approximately $80K in PROF purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in PROF?
This PROF page updates as soon as new STOCK Act disclosures are filed for Profound Medical Corp.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.